Blooom, Inc. Abbott Laboratories Transaction History

Blooom, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $196,076 - $236,993	-1,921 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $14,252 - $17,380	125 Added 6.96%	1,921 $233,000
Q4 2021 Jan 19, 2022	BUY	$115.53 - $141.46 $2,310 - $2,829	20 Added 1.13%	1,796 $251,000
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $658,662 - $728,672	-5,646 Reduced 76.07%	1,776 $217,000
Q2 2021 Sep 23, 2021	BUY	$105.79 - $124.53 $8,992 - $10,585	85 Added 1.16%	7,422 $838,000
Q1 2021 Oct 21, 2021	SELL	$108.84 - $128.23 $31,890 - $37,571	-293 Reduced 3.84%	7,337 $880,000
Q4 2020 Oct 21, 2021	BUY	$105.0 - $114.42 $801,150 - $873,024	7,630 New	7,630 $826,000

3,181

1.33B

8.62M

7.18M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Blooom, Inc., based on Form 13F filings with the SEC.

Stay updated on Blooom, Inc. with notifications on news.